Literature DB >> 34071158

Small Cell Lung Cancer: A New Era Is Beginning?

Alessandro Morabito1, Christian Rolfo2.   

Abstract

Small cell lung cancer (SCLC) accounts for about 15% of all lung cancers and it is the most aggressive one [...].

Entities:  

Year:  2021        PMID： 34071158     DOI： 10.3390/cancers13112646

Source DB:  PubMed          Journal:  Cancers (Basel)        ISSN： 2072-6694            Impact factor:   6.639


  11 in total

Review 1.  Treatment of small cell lung cancer.

Authors:  Alessandro Morabito; Guido Carillio; Gennaro Daniele; Maria Carmela Piccirillo; Agnese Montanino; Raffaele Costanzo; Claudia Sandomenico; Pasqualina Giordano; Nicola Normanno; Francesco Perrone; Gaetano Rocco; Massimo Di Maio
Journal:  Crit Rev Oncol Hematol       Date:  2014-04-02       Impact factor: 6.312

2.  EPAC-lung: European pooled analysis of the prognostic value of circulating tumour cells in small cell lung cancer.

Authors:  Victoria Foy; Colin R Lindsay; Alexandra Carmel; Fabiola Fernandez-Gutierrez; Matthew G Krebs; Lynsey Priest; Mathew Carter; Harry J M Groen; T Jeroen N Hiltermann; Antonella de Luca; Francoise Farace; Benjamin Besse; Leon Terstappen; Elisabetta Rossi; Alessandro Morabito; Francesco Perrone; Andrew Renehan; Corinne Faivre-Finn; Nicola Normanno; Caroline Dive; Fiona Blackhall; Stefan Michiels
Journal:  Transl Lung Cancer Res       Date:  2021-04

Review 3.  PARP Inhibitors in Small-Cell Lung Cancer: Rational Combinations to Improve Responses.

Authors:  Erik H Knelson; Shetal A Patel; Jacob M Sands
Journal:  Cancers (Basel)       Date:  2021-02-10       Impact factor: 6.639

Review 4.  History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature.

Authors:  Chiara Lazzari; Aurora Mirabile; Alessandra Bulotta; Maria Grazia Viganó; Francesca Rita Ogliari; Stefania Ippati; Italo DellOca; Mariacarmela Santarpia; Vincenza Lorusso; Martin Reck; Vanesa Gregorc
Journal:  Cancers (Basel)       Date:  2021-02-27       Impact factor: 6.639

5.  Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma.

Authors:  Hsiao-Ling Chen; Yu-Kang Tu; Hsiu-Mei Chang; Tai-Huang Lee; Kuan-Li Wu; Yu-Chen Tsai; Mei-Hsuan Lee; Chih-Jen Yang; Jen-Yu Hung; Inn-Wen Chong
Journal:  Cancers (Basel)       Date:  2020-12-03       Impact factor: 6.639

Review 6.  Pathology and Classification of SCLC.

Authors:  Maria Gabriela Raso; Neus Bota-Rabassedas; Ignacio I Wistuba
Journal:  Cancers (Basel)       Date:  2021-02-16       Impact factor: 6.639

Review 7.  Small Cell Lung Cancer: State of the Art of the Molecular and Genetic Landscape and Novel Perspective.

Authors:  Valeria Denninghoff; Alessandro Russo; Diego de Miguel-Pérez; Umberto Malapelle; Amin Benyounes; Allison Gittens; Andres Felipe Cardona; Christian Rolfo
Journal:  Cancers (Basel)       Date:  2021-04-06       Impact factor: 6.639

Review 8.  Surgery in Small-Cell Lung Cancer.

Authors:  Nicola Martucci; Alessandro Morabito; Antonello La Rocca; Giuseppe De Luca; Rossella De Cecio; Gerardo Botti; Giuseppe Totaro; Paolo Muto; Carmine Picone; Giovanna Esposito; Nicola Normanno; Carmine La Manna
Journal:  Cancers (Basel)       Date:  2021-01-21       Impact factor: 6.639

Review 9.  Novel Cytotoxic Chemotherapies in Small Cell Lung Carcinoma.

Authors:  Diego Cortinovis; Paolo Bidoli; Stefania Canova; Francesca Colonese; Maria Gemelli; Maria Luisa Lavitrano; Giuseppe Luigi Banna; Stephen V Liu; Alessandro Morabito
Journal:  Cancers (Basel)       Date:  2021-03-08       Impact factor: 6.639
View more
  1 in total

Review 1.  Epigenetics of Most Aggressive Solid Tumors: Pathways, Targets and Treatments.

Authors:  Javier Martinez-Useros; Mario Martin-Galan; Maria Florez-Cespedes; Jesus Garcia-Foncillas
Journal:  Cancers (Basel)       Date:  2021-06-27       Impact factor: 6.639
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.